Polascik, Thomas J.
Durham VA Medical Center,
United States
2025 Rank: 68417
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Urology & Nephrology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 742 out of 92052 Researchers
Data For The Year: 2025
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 68417 | 71396 |
| Total Cites | 9021 | 10350 |
| H-index | 54 | 57 |
| Hm-index | 20 | 21 |
| Number of Single Authored Papers | 5 | 5 |
| Total Cites to Single Authored Papers | 76 | 76 |
| Number of Single+First Authored Papers | 37 | 37 |
| Total Cites to Single+First Authored Papers | 1816 | 2026 |
| Number of Single+First+Last Authored Papers | 148 | 148 |
| Total Cites to Single+First+Last Authored Papers | 4634 | 5297 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 7848 | 8537 |
| Ratio of Total Citations to Distinct Citing Papers | 1.15 | 1.21 |
| Self-Citation Percentage |
12.84%
|
|
Polascik, Thomas J.
Duke University School of Medicine,
United States
2024 Rank: 66093
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Urology & Nephrology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 731 out of 87532 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 66093 | 69104 |
| Total Cites | 8583 | 9884 |
| H-index | 52 | 55 |
| Hm-index | 19 | 21 |
| Number of Single Authored Papers | 5 | 5 |
| Total Cites to Single Authored Papers | 76 | 76 |
| Number of Single+First Authored Papers | 37 | 37 |
| Total Cites to Single+First Authored Papers | 1782 | 1992 |
| Number of Single+First+Last Authored Papers | 148 | 148 |
| Total Cites to Single+First+Last Authored Papers | 4415 | 5066 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 7483 | 8162 |
| Ratio of Total Citations to Distinct Citing Papers | 1.15 | 1.21 |
| Self-Citation Percentage |
13.16%
|
|
Polascik, Thomas J.
Duke Cancer Institute,
United States
2023 Rank: 60699
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Urology & Nephrology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 678 out of 82885 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 60699 | 62729 |
| Total Cites | 8810 | 10117 |
| H-index | 51 | 54 |
| Hm-index | 19 | 21 |
| Number of Single Authored Papers | 9 | 9 |
| Total Cites to Single Authored Papers | 76 | 76 |
| Number of Single+First Authored Papers | 42 | 42 |
| Total Cites to Single+First Authored Papers | 1760 | 1973 |
| Number of Single+First+Last Authored Papers | 160 | 160 |
| Total Cites to Single+First+Last Authored Papers | 4395 | 5044 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 7638 | 8319 |
| Ratio of Total Citations to Distinct Citing Papers | 1.15 | 1.22 |
| Self-Citation Percentage |
12.92%
|
|
Polascik, Thomas J.
Duke Cancer Institute,
United States
2022 Rank: 56913
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Urology & Nephrology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 653 out of 79729 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 56913 | 59690 |
| Total Cites | 8348 | 9598 |
| H-index | 49 | 52 |
| Hm-index | 19 | 20 |
| Number of Single Authored Papers | 5 | 5 |
| Total Cites to Single Authored Papers | 72 | 72 |
| Number of Single+First Authored Papers | 37 | 37 |
| Total Cites to Single+First Authored Papers | 1730 | 1938 |
| Number of Single+First+Last Authored Papers | 150 | 150 |
| Total Cites to Single+First+Last Authored Papers | 4200 | 4831 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 7247 | 7893 |
| Ratio of Total Citations to Distinct Citing Papers | 1.15 | 1.22 |
| Self-Citation Percentage |
13.02%
|
|
Polascik, Thomas J.
Duke Cancer Institute,
United States
2021 Rank: 55516
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Urology & Nephrology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 632 out of 76322 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 55516 | 57029 |
| Total Cites | 8109 | 9333 |
| H-index | 47 | 51 |
| Hm-index | 19 | 20 |
| Number of Single Authored Papers | 6 | 6 |
| Total Cites to Single Authored Papers | 73 | 73 |
| Number of Single+First Authored Papers | 38 | 38 |
| Total Cites to Single+First Authored Papers | 1681 | 1883 |
| Number of Single+First+Last Authored Papers | 151 | 151 |
| Total Cites to Single+First+Last Authored Papers | 4071 | 4689 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 7035 | 7666 |
| Ratio of Total Citations to Distinct Citing Papers | 1.15 | 1.22 |
| Self-Citation Percentage |
13.11%
|
|
Polascik, Thomas J.
Duke University Medical Center,
United States
2020 Rank: 52751
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Urology & Nephrology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 634 out of 64516 Researchers
Data For The Year: 2020
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 52751 | 53774 |
| Total Cites | 7587 | 8743 |
| H-index | 46 | 50 |
| Hm-index | 18 | 20 |
| Number of Single Authored Papers | 7 | 7 |
| Total Cites to Single Authored Papers | 67 | 67 |
| Number of Single+First Authored Papers | 41 | 41 |
| Total Cites to Single+First Authored Papers | 1633 | 1833 |
| Number of Single+First+Last Authored Papers | 154 | 154 |
| Total Cites to Single+First+Last Authored Papers | 3833 | 4435 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 6562 | 7152 |
| Ratio of Total Citations to Distinct Citing Papers | 1.16 | 1.22 |
| Self-Citation Percentage |
13.22%
|
|
Related Profiles
Featured Profiles
Partner with TOPSCINET
Reach science enthusiasts and researchers across the site. Write to business@topscinet.com and our marketing team will send a proposal built around your banner ad goals.